Related by context. All words. (Click for frequent words.) 76 prostate carcinoma 75 ADPKD 75 colorectal adenocarcinoma 75 epithelial tumors 75 lung carcinomas 75 ovarian carcinoma 75 carcinoembryonic antigen 74 gastric adenocarcinoma 74 NMIBC 74 sarcomatoid 74 renal cell carcinomas 74 breast carcinomas 73 colorectal adenoma 73 pancreatic adenocarcinoma 73 E selectin 73 inducible nitric oxide synthase 73 hyperplastic 73 cisplatin resistant 73 SSc 73 adenomatous 73 urothelial carcinoma 73 prostate cancer CaP 73 pancreatic endocrine 73 interleukin IL -# 73 nonmetastatic 73 mucinous 73 serous ovarian cancer 73 cell carcinomas 73 mutated K ras 73 Papillary 73 basal cell carcinoma BCC 73 ERalpha 73 leiomyomas 73 invasive ductal 72 cell adhesion molecule 72 Endometrial 72 gastric carcinoma 72 hepatoma 72 neoplastic 72 papillary renal cell carcinoma 72 malignant prostate 72 tumoral 72 histologic subtype 72 metachronous 72 Fas ligand 72 fibrin deposition 72 epithelial ovarian 72 peritoneal carcinomatosis 72 K ras mutations 72 syngeneic 72 pleomorphic 72 leiomyoma 72 PTPN# 72 isoenzyme 72 pDC 72 leukocyte adhesion 72 epithelioid 72 prostate adenocarcinoma 72 PCa 71 TIMP 1 71 Leydig cell 71 Gleevec resistant 71 papillary carcinoma 71 TRAIL R2 71 metastatic gastric 71 FGFR3 71 ABCB1 71 Clusterin 71 paraganglioma 71 cyclin E 71 urothelial 71 Immunohistochemical analysis 71 breast carcinoma 71 TIMP 71 immunohistochemical staining 71 urothelial cancer 71 pulmonary metastases 71 neoplasm 71 monocytic 71 Upregulation 71 MALT lymphoma 71 antiproliferative effects 71 nonalcoholic steatohepatitis NASH 71 TNFalpha 71 Sezary syndrome 71 leukemia AML 71 MMP9 71 myeloperoxidase 71 lobular carcinoma 71 ERK1 2 71 GSTT1 71 lactate dehydrogenase 71 hamartomas 71 BRAF V#E 71 idiopathic myelofibrosis 71 proto oncogene 71 mutated KRAS 71 immunoreactivity 71 renal tumors 71 PDGFR 71 HepG2 cells 71 androgen receptor AR 71 paragangliomas 71 metastatic malignant 71 situ LCIS 71 Macrophage 71 GSTP1 71 Lymphocytic 70 nodal metastasis 70 ADAMTS# 70 hepatocellular carcinomas 70 HER2 receptor 70 murine model 70 treat benign prostatic 70 androgen dependent 70 induces apoptosis 70 lymphangiogenesis 70 recurrent glioblastoma multiforme 70 precursor lesions 70 lymphocytosis 70 metaplasia 70 colon carcinoma 70 adenoma 70 endometrial hyperplasia 70 pancreatic carcinoma 70 LPS induced 70 uPA 70 metastatic neuroendocrine tumors 70 vascular endothelial 70 osteolytic 70 Anaplastic 70 B7 H3 70 EGF receptors 70 myelofibrosis polycythemia vera 70 thyroid carcinoma 70 FLT3 70 HNSCC 70 activin 70 chemoresistant 70 liver metastasis 70 seminoma 70 Adenomas 70 CIN2 + 70 hypoxia inducible factor 70 atypical hyperplasia 70 PAOD 70 lung adenocarcinomas 70 MGd 70 squamous cell carcinoma SCC 70 prostate epithelial cells 70 IGF1R 70 Squamous 70 underlying vasculopathy 70 TNF α 70 gastric cancers 70 Immunohistochemical staining 70 pheochromocytoma 70 locoregional recurrence 70 neuroendocrine cancers 70 TRAIL R1 70 neoplastic cells 70 BRAF V#E mutation 70 VEGF induced 70 Cholangiocarcinoma 70 prognostic indicator 70 LRP6 70 IL 1ß 70 cytokeratin 70 alanine aminotransferase ALT 70 lymph node metastasis 70 papillary thyroid carcinoma 70 unresectable tumors 70 neoplastic lesions 70 renal fibrosis 70 carcinoid tumor 70 pT2 70 GNAQ 70 kidney urologic 70 fibrogenesis 70 pathophysiological effects 70 LNCaP cells 70 Epidermal Growth Factor Receptor 70 vWF 70 neoplasias 70 choroidal neovascularization 70 tumor xenograft models 70 upregulates 70 cervical lymph nodes 69 COX2 69 mediated inhibition 69 LHRH receptor positive 69 chemokine receptor 69 plasminogen activator inhibitor 69 ductal carcinomas 69 adenocarcinomas 69 Leukemias 69 alveolar epithelial cells 69 grade cervical intraepithelial 69 intestinal metaplasia 69 primary hyperparathyroidism 69 neuroblastoma tumors 69 gastric cardia 69 EGFR receptor 69 HER2 overexpression 69 VEGFR1 69 RRM1 69 GPC5 69 bone metastasis 69 haematopoietic 69 colorectal pancreatic 69 B Cell Lymphoma 69 VEGF receptor 69 μg ml 69 CagA 69 bronchoalveolar lavage 69 EGF receptor 69 lymphoid cells 69 Fibroblast 69 prostate cancer PCa 69 pulmonary metastasis 69 metastatic colorectal 69 transgene expression 69 choriocarcinoma 69 chronic eosinophilic leukemia 69 E#F# 69 atherosclerotic lesions 69 thyrotoxicosis 69 micrometastases 69 ERBB2 69 oesophageal adenocarcinoma 69 TTR gene 69 protein tyrosine phosphatase 1B 69 thyroglobulin 69 cholelithiasis 69 Malignant Melanoma 69 gene polymorphism 69 gastrointestinal stromal tumors GISTs 69 uterine cervix 69 distant metastasis 69 Overexpression 69 ductal adenocarcinoma 69 LRAT 69 biliary tract cancer 69 intrahepatic 69 HGPIN 69 Cathepsin B 69 transitional cell carcinoma 69 bronchial epithelial cells 69 premalignant 69 IGFBP 69 mitogen activated protein kinase 69 CD# expression [001] 69 LRP5 69 Pancreatic 69 cytokine receptor 69 c MYC 69 HER2 amplification 69 EGFR HER2 69 regulated kinase 69 lymphocytic 69 renal carcinoma 69 TET2 69 immunostaining 69 NQO1 69 upregulating 69 poly ADP ribose polymerase 69 malignant pleural mesothelioma 69 extramedullary 69 Epstein Barr virus EBV 69 mRNA expression 69 CYT# potent vascular disrupting 69 NKG2D 69 hyperhomocysteinemia 69 carcinoid 69 Epstein Barr Virus EBV 69 transplantation HCT 69 node metastases 69 ErbB2 positive 69 glucose transporter 69 hypophosphatemia 69 TGF ß1 69 osteosarcomas 69 eosinophil count 69 alkylating agent 69 CYP#B# 69 colorectal neoplasms 69 cholangiocarcinoma 69 surgically resected 69 SOD2 gene 69 nasopharyngeal carcinoma 69 bladder carcinoma 69 esophageal gastric 68 submandibular gland 68 thymoma 68 IL6 68 bFGF 68 CEACAM1 68 aplasia 68 Metastases 68 hypermethylated 68 induced apoptosis 68 prostatic tissue 68 invasive carcinomas 68 tumor necrosis 68 acinar 68 TGF alpha 68 ^ sup #m 68 Hurthle cell 68 HER2 expression 68 tumors GIST 68 receptor tyrosine kinase inhibitor 68 HbF 68 histologically 68 adrenocortical cancer 68 Factor Receptor 68 intercellular adhesion molecule 68 IGFBP 3 68 Metastatic 68 MMP2 68 WT1 68 VEGF expression 68 iNOS 68 COL#A# 68 molecule epidermal 68 selective modulator 68 xenograft tumors 68 Mitomycin C 68 pro angiogenic 68 metabolizing enzyme 68 node metastasis 68 thyrotropin 68 CC genotype 68 demonstrated antitumor activity 68 KRAS oncogene 68 Basal Cell 68 biochemical relapse 68 orthotopic 68 adrenalectomy 68 lymphomas leukemias 68 cyclooxygenase 2 68 IL 1beta 68 Elevated serum 68 Ribavirin causes 68 lactate dehydrogenase LDH 68 promoter methylation 68 Chronic pancreatitis 68 macroalbuminuria 68 catenin 68 adipogenic 68 atrophic gastritis 68 malignant pancreatic 68 pancreatic islet 68 thyroid peroxidase 68 CDKN2A 68 deacetylation 68 antigen PSA levels 68 lymphoid organs 68 somatostatin receptors 68 HIV HCV coinfected 68 lung metastasis 68 neurofibromas 68 uPAR 68 umbilical vein 68 constitutively expressed 68 osteoblastic 68 CD# + [001] 68 fallopian tube carcinoma 68 gastric mucosa 68 micrometastasis 68 tryptase 68 protein tyrosine phosphatase 68 alkaline phosphatase ALP 68 Cytotoxic T 68 Ischemic 68 hepatocellular carcinoma HCC 68 rs# [002] 68 hypereosinophilic syndrome 68 adrenocortical 68 radiosensitivity 68 glutamyl 68 advanced adenoma 68 IFN beta 68 seminomas 68 colorectal tumors 68 monocytes macrophages 68 ERK pathway 68 advanced adenomas 68 uveal melanoma 68 T1c 68 urothelium 68 neutrophil count 68 germline mutations 68 immunohistochemical 68 ovarian pancreatic 68 transthyretin amyloidosis 68 germline mutation 68 P selectin 68 pegylated liposomal doxorubicin 68 inverse agonist 68 skeletal metastases 68 pheochromocytomas 68 ductal cancer 68 trans retinoic acid 68 renal pelvis 68 AGTR1 68 familial ALS 68 thrombocytopenic 68 cutaneous melanoma 68 Allogeneic 68 carcinoma HCC 68 p# mutation 68 mesangial 68 histological subtype 68 Polymorphisms 68 neovascular 68 FasL 68 T#I [002] 68 NKX2 68 Rap1 68 localized renal 68 HLA DR 68 arterial calcification 68 cyclin dependent kinase inhibitor 68 recurrent ovarian 68 exocrine 68 ptau 68 hypoperfusion 68 MTHFR 68 gastrointestinal stromal tumor 68 N. gonorrhoeae 68 tumor suppressor protein 68 Interferon gamma 68 extrahepatic 68 benign neoplasms 68 NSCLC tumors 68 null mice 68 nutlin 3a 68 FGFR2 68 operable breast cancer 68 complement inhibitor eculizumab 68 epididymal 68 malignant ovarian 68 JAK2 enzyme 68 constitutively active 68 GISTs 68 glomerular 68 Angiotensin converting enzyme 68 mTOR mammalian target 68 premalignant lesions 68 pan HDAC inhibitor 68 MGUS 68 Carcinomas 68 colony stimulating factor 68 MMP# 68 Î ² 68 SGPT 68 Hashimoto thyroiditis 67 apoptotic pathway 67 metastatic lesions 67 factor HGF 67 Hematologic 67 severe neutropenia 67 fibroma 67 pancreatic lung 67 malignant lymphoma 67 bladder ovarian 67 PKC inhibitor 67 telomerase reverse transcriptase 67 essential thrombocythemia ET 67 nephrogenic 67 elastase 67 effector function 67 carcinoids 67 DFMO 67 BCG refractory 67 hepatocellular 67 alanine aminotransferase 67 eccrine 67 MAPK pathway 67 HIF 1a 67 mononuclear cells 67 adenomatous polyps 67 Akt activation 67 chemo resistant 67 Oncogenic 67 uricase 67 Surgical resection 67 Monocyte 67 metastatic bladder 67 neovascularization 67 mTOR inhibitors 67 bone morphogenic protein 67 essential thrombocythemia 67 TGF ß 67 pCR 67 situ CIS 67 tumor infiltrating lymphocytes 67 myelodysplastic myeloproliferative diseases 67 p# Shc 67 deletion 5q 67 metastatic pancreatic 67 ß catenin 67 papillary RCC 67 monogenic 67 adriamycin 67 ErbB2 67 soluble tumor necrosis 67 ximelagatran 67 hepatic lipase 67 cervical carcinoma 67 renal allograft 67 breast endometrial 67 clonogenic 67 microvessel density 67 metalloproteinase 67 immunoreactive 67 thyroid hormone receptor 67 breast pancreatic 67 MSH2 67 Adjuvant chemotherapy 67 Neutrophil 67 transthyretin 67 neointimal hyperplasia 67 APOL1 67 squamous carcinoma 67 pancreatic prostate 67 p# MAPK 67 polypoid 67 carcinoid tumors 67 nucleoside analog 67 NF kB pathway 67 malignant neoplasm 67 triiodothyronine 67 interferon γ 67 selective inhibition 67 squamous cell lung cancer 67 allogeneic bone marrow 67 acute humoral rejection 67 Diffuse Large B 67 interleukin IL -6 67 TNFa 67 Tie2 67 hA# 67 endothelial activation 67 IDH1 mutation 67 c MET 67 malignant growths 67 p# mutations 67 polyposis 67 micronuclei 67 aspartate aminotransferase 67 Lp PLA 2 67 aminotransferase 67 basal cell nevus syndrome 67 NKX#.# 67 HER2/neu 67 nonischemic 67 Prostatic 67 Carcinoid tumors 67 HER2 neu 67 CD#b 67 colorectal gastric 67 plasma kallikrein 67 GSTM1 67 ANCA associated 67 hepatorenal syndrome 67 cancer mCRC 67 hepatocellular carcinoma 67 oncoprotein 67 colorectal tumor 67 malignant lymphomas 67 NOD SCID mice 67 Caveolin 1 67 pT3 67 cystic lesions 67 C5aR 67 cyclooxygenase 67 HBeAg negative 67 hematopoietic cancers 67 monocyte chemotactic protein 67 autophagic 67 myofibroblast 67 neovascularisation 67 pituitary adenomas 67 lymphoproliferative disorders 67 PEDF 67 HDACi 67 selective agonist 67 motor neuron degeneration 67 PSA nadir 67 antibody MT# 67 endometrioid 67 metastatic malignant melanoma 67 epithelial ovarian cancer 67 lesional 67 subependymal giant cell 67 leukemic cell 67 p# biomarker 67 polycythemia vera essential thrombocythemia 67 bladder tumors 67 bladder cancers 67 LV dysfunction 67 malignant ascites 67 Carcinoma 67 Antitumor Activity 67 immunopathology 67 hormone receptor negative 67 CCL# 67 bronchogenic carcinoma 67 activated lymphocytes 67 endoglin 67 lymphoblasts 67 pancreatic islet cell 67 INCB# [003] 67 cytopenia 67 irreversible inhibitor 67 anaplastic lymphoma kinase 67 CD#c 67 trophoblast cells 67 tumor xenografts 67 CDK inhibitor 67 IGFBP2 67 prostate carcinomas 67 diabetes mellitus DM 67 mononuclear 67 rs# [004] 67 p# mitogen activated 67 Autoantibodies 67 extracellular domain 67 immunocompetent 67 Barrett esophagus BE 67 papillomas 67 intestinal mucosal 67 chronic myeloid 67 MAP kinase 67 tyrosine kinase receptor 67 anterior uveitis 67 precancerous condition 67 cis retinoic acid 67 splenic 67 metastatic GIST 67 IgA antibodies 67 tumorigenicity 67 monoclonal gammopathy 67 phosphoprotein 67 EGFR tyrosine kinase inhibitors 67 contralateral breast 67 intraepithelial 67 proximal colon 67 hyperphenylalaninemia HPA due 67 submucosal 67 E. faecalis 67 proapoptotic 67 lipoxygenase 67 receptor blocker 67 Sjögren syndrome 67 Enzastaurin 67 thymidylate synthase TS 67 Cryptococcus neoformans 67 PDGF receptor 67 HIF 1alpha 67 Endometrial cancer 67 osteoblast 67 trophoblasts 67 osteoclastic 67 HCT# 67 esophageal squamous cell carcinoma 67 Ki# 67 intimal hyperplasia 67 perivascular 67 precancerous cervical 67 downregulates 67 extracranial 67 lung metastases 67 5 HT1A 67 Acute myeloid leukemia 67 Angiotensin 67 intracranial hemorrhage ICH 67 polycythemia vera PV 67 neoplasms 67 beta1 integrin 67 adhesion molecule 67 vimentin 67 IgG4 67 relapsed MM 67 cyclooxygenase COX 67 serine protease 67 regulated kinase ERK 67 Heterozygous 67 phosphate S1P 67 intestinal polyps 67 multiple myeloma MM 67 multikinase inhibitor 67 monocyte chemoattractant protein 67 parathyroid carcinoma 67 prostate cancer CRPC 67 stage IIIb IV 67 metastatic renal cell carcinoma 67 Protein Kinase C 67 Aromatase 67 flutamide 67 microglial 67 schwannomas 67 ectopic expression 67 Glucocorticoids 67 serine threonine 67 potent inducer 67 Diabetic nephropathy 67 thymic 67 retinoic acid receptor 66 periventricular 66 glycogen synthase kinase 66 gastric carcinomas 66 castrate resistant prostate cancer 66 radiochemotherapy 66 acute myeloid 66 T1a 66 histopathologic examination 66 receptor tyrosine kinase 66 c Src 66 IgA deficiency 66 IFN α 66 Prostatitis 66 surgically resectable 66 Angiotensin II 66 Atypical Hemolytic Uremic Syndrome 66 hydrolase 66 IL 1β 66 mouse xenograft models 66 CMV infection 66 hamartoma 66 β catenin 66 PTHrP 66 gefitinib Iressa 66 gadolinium enhanced 66 p#INK#a 66 TGF β 66 receptor inhibitor 66 idiopathic PAH 66 chronic granulomatous disease 66 Dystrophin 66 mutated p# 66 Multiple Myeloma MM 66 MLH1 66 pulmonary alveolar 66 metastatic lymph nodes 66 dephosphorylation 66 mediated apoptosis 66 serine proteases 66 supernatants 66 intravascular hemolysis 66 total thyroidectomy 66 EGFR mutant 66 Leydig cells 66 occlusive disease 66 lung fibrosis 66 gastrointestinal stromal tumors GIST 66 myeloproliferative neoplasms 66 FGFR1 66 cellularity 66 peroxisomal 66 fallopian tube cancers 66 constitutively activated 66 abnormal p# 66 Asymptomatic 66 type plasminogen activator 66 transfusion syndrome 66 systemic amyloidosis 66 C#Y 66 acute aortic dissection 66 cytopenias 66 kidney allograft 66 FGFR4 66 AMACR 66 chemoresistance 66 factor PlGF 66 Inactivation 66 p# activation 66 neointimal 66 Gorlin syndrome 66 PBMCs 66 synovial fibroblasts 66 oncogenic transformation 66 bronchoalveolar 66 leukocyte counts 66 nonsmall cell lung cancer 66 ara C 66 BRCA1 BRCA2 66 Tumor Necrosis Factor 66 urate oxidase 66 ischemia reperfusion injury 66 Lymphocytes 66 CDH1 66 glucosylceramide 66 serum prostate 66 CTGF 66 mucosal inflammation 66 Mucosal 66 BRAF mutation 66 endocrine tumors 66 Glioma 66 CD4 + T lymphocytes 66 #HT#A 66 advanced hepatocellular carcinoma 66 gastric corpus 66 neoplasia 66 gamma secretase inhibitor 66 eotaxin 66 Candida infection 66 peritumoral 66 DNA adducts 66 esophagogastric junction 66 aberrantly activated 66 cardiac dysfunction 66 TGF β1 66 NF kappaB activation 66 miR #a [001] 66 GPC3 66 Nedd4 66 AT1R 66 hypermethylation 66 transcriptional repressor 66 cytotoxic effects 66 leukocytosis 66 Adjuvant therapy 66 EGFr 66 astrocytic 66 receptor monoclonal antibody 66 paraneoplastic 66 antibody mediated 66 nonmelanoma skin cancers 66 immunoblotting 66 erythropoietic 66 E cadherin expression 66 medullary thyroid cancer 66 microsatellite instability 66 hematological parameters 66 β1 66 V#F mutation 66 benign prostatic hypertrophy BPH 66 hypervascular tumors 66 lobular 66 Phosphorylation 66 melanocyte 66 cytoreduction 66 1beta 66 prognostic marker 66 cTnI 66 thrombocytosis 66 NOTCH1 66 lymph node metastases 66 pretransplant 66 phosphorylates 66 Endothelial 66 CP CPPS 66 epithelia 66 HBeAg 66 corticosteroid dexamethasone 66 PKC beta 66 cranial irradiation 66 colorectal adenomas 66 selectively inhibited 66 PNET 66 androgen independent 66 breast cancer metastasis 66 isoenzymes 66 choroidal 66 eNOS 66 Rho kinase 66 PTEN protein 66 topoisomerase II inhibitor 66 histologically confirmed 66 TGF beta1 66 lysophosphatidic acid 66 cytidine 66 TP# mutations 66 Mutational 66 ß amyloid 66 F FDG PET 66 hydronephrosis 66 hip osteonecrosis avascular 66 PC3 cells 66 ASCUS 66 intratumoral 66 missense mutation 66 lymphoid 66 stage IIIB 66 CCR1 66 endothelin receptor 66 uterine tumors 66 extracellular signal 66 esophageal carcinoma 66 fulminant hepatic failure 66 rs# [001] 66 chloride secretion 66 proteoglycan 66 Parathyroid hormone 66 Aurora Kinase 66 supratentorial 66 CHEK2 66 bioavailable testosterone 66 steroidogenic 66 phospholipase A2 66 diagnostic biomarker 66 PROSTVAC VF 66 c myc gene 66 beta subunit 66 cathepsin B 66 cyclophosphamide methotrexate 66 azacytidine 66 endometrial carcinoma 66 pelvic lymphadenectomy 66 CLL cells 66 intravesical therapy 66 myeloproliferative diseases 66 hepatic cirrhosis 66 SNP rs# [001] 66 orally administered inhibitor 66 obstructive coronary 66 TEL AML1 66 thymidine kinase 66 TNF Tumor Necrosis Factor 66 malignant fibrous histiocytoma 66 Histologic 66 TRAIL induced apoptosis 66 methylenetetrahydrofolate reductase 66 chemosensitivity 66 leukocyte count 66 apo B 66 Bleomycin 66 Pathway Inhibitor 66 Six3 66 Parathyroid Hormone 66 PPARgamma 66 astrocytomas 66 taxane resistant 66 Progenitor Cells 66 unmutated 66 Glioblastoma Multiforme 66 CMV infections 66 mitogenic 66 TT genotype 66 redox active 66 mesotheliomas 66 Basal cell 66 FluCAM arm 66 castration resistant 66 synovial cells 66 Advanced Renal Cell 66 CTAP# Capsules 66 grade squamous intraepithelial 66 PTP 1B 66 hydroxylase 66 baseline LDH 66 herpesviruses 66 Adenocarcinoma 66 allogeneic HSCT 66 adrenal cortex 66 PTLD 66 muscarinic receptors 66 capillary endothelial cells 66 underwent surgical resection 66 Kupffer cells 66 Thiazolidinediones 66 eIF 4E 66 matrix metalloproteinases 66 activating mutations 66 neuroendocrine carcinoma 66 endometrial 66 intraepithelial neoplasia 66 Azacitidine 66 radioiodine therapy 66 tunica vaginalis 66 NFkB 66 phosphatidylinositol 3 66 serum calcium levels 66 steroidogenesis 66 p#NTR 66 transgenic rats 66 B7 H4 66 RIP1 66 choroidal neovascularization CNV 66 Naive Patients 66 geographic atrophy 66 malignant transformation 66 PDGFR alpha 66 annexin V 66 ERK signaling 66 Nodules 66 polymorphonuclear leukocytes 66 post transplant lymphoproliferative 66 Haptoglobin 66 thalidomide Thalomid 66 caveolin 1 66 S. pyogenes 66 complete cytogenetic response 66 Decitabine 66 Hypotension 66 mycosis fungoides